{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T21:37:46Z","timestamp":1789767466751,"version":"4.0.1"},"reference-count":13,"publisher":"Springer Science and Business Media LLC","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Neurooncol"],"published-print":{"date-parts":[[2011,9]]},"DOI":"10.1007\/s11060-011-0551-3","type":"journal-article","created":{"date-parts":[[2011,3,3]],"date-time":"2011-03-03T19:29:15Z","timestamp":1299180555000},"page":"811-815","source":"Crossref","is-referenced-by-count":14,"title":["Leptomeningeal disease in oligodendroglial tumors: a population-based study"],"prefix":"10.1007","volume":"104","author":[{"given":"Gloria","family":"Rold\u00e1n","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer","family":"Chan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Misha","family":"Eliasziw","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. Gregory","family":"Cairncross","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter A.","family":"Forsyth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2011,3,4]]},"reference":[{"key":"551_CR1","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/S0090-3019(03)00167-8","volume":"60","author":"HH Engelhard","year":"2003","unstructured":"Engelhard HH, Stelea A, Mundt A (2003) Oligodendroglioma and anaplastic oligodendroglioma: clinical features, treatment and prognosis. Surg Neurol 60:443\u2013456","journal-title":"Surg Neurol"},{"key":"551_CR2","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1634\/theoncologist.2008-0248","volume":"14","author":"J Bromberg","year":"2009","unstructured":"Bromberg J, Van den Bent MJ (2009) Oligodendrogliomas: molecular biology and treatment. The Oncologist 14:155\u2013163","journal-title":"The Oncologist"},{"key":"551_CR3","doi-asserted-by":"crossref","first-page":"2707","DOI":"10.1200\/JCO.2005.04.3414","volume":"24","author":"G Cairncross","year":"2006","unstructured":"Cairncross G, Berkey B, Shaw E et al (2006) Phase III trial of chemotherapy plus radiotherapy compared with radiotherapy alone for pure and mixed anaplastic oligodendroglioma: Intergroup Radiation Therapy Oncology Group Trial 9402. J Clin Oncol 24:2707\u20132714","journal-title":"J Clin Oncol"},{"key":"551_CR4","doi-asserted-by":"crossref","first-page":"2715","DOI":"10.1200\/JCO.2005.04.6078","volume":"24","author":"MJ Bent van den","year":"2006","unstructured":"van den Bent MJ, Carpentier AF, Brandes AA et al (2006) Adjuvant procarbazine, lomustine, and vincristine improves progression-free survival but not overall survival in newly diagnosed anaplastic oligodendrogliomas and oligoastrocytomas: a randomized European Organization for Research and Treatment of Cancer phase III trial. J Clin Oncol 24:2715\u20132722","journal-title":"J Clin Oncol"},{"key":"551_CR5","doi-asserted-by":"crossref","first-page":"9852","DOI":"10.1158\/0008-5472.CAN-06-1796","volume":"66","author":"RB Jenkins","year":"2006","unstructured":"Jenkins RB, Blair H, Ballman KV et al (2006) A t(1;19)(q10;p10) mediates the combined deletions of 1p and 19q and predicts a better prognosis of patients with oligodendroglioma. Cancer Res 66:9852\u20139861","journal-title":"Cancer Res"},{"key":"551_CR6","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1093\/jnci\/90.19.1473","volume":"90","author":"JG Cairncross","year":"1998","unstructured":"Cairncross JG, Ueki K, Zlatescu MC et al (1998) Specific genetic predictors of chemotherapeutic response and survival in patients with anaplastic oligodendrogliomas. J Natl Cancer Inst 90:1473\u20131479","journal-title":"J Natl Cancer Inst"},{"key":"551_CR7","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1016\/S0360-3016(00)00703-3","volume":"48","author":"GS Bauman","year":"2000","unstructured":"Bauman GS, Ino Y, Ueki K et al (2000) Allelic loss of chromosome 1p and radiotherapy plus chemotherapy in patients with oligodendrogliomas. Int J Radiat Oncol Biol Phys 48:825\u2013830","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"551_CR8","first-page":"839","volume":"7","author":"Y Ino","year":"2001","unstructured":"Ino Y, Betensky RA, Zlatescu MC, Sasaki H et al (2001) Molecular subtypes of anaplastic oligodendroglioma: implications for patient management at diagnosis. Clin Cancer Res 7:839\u2013845","journal-title":"Clin Cancer Res"},{"key":"551_CR9","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1017\/S0317167100008647","volume":"35","author":"G Rold\u00e1n","year":"2008","unstructured":"Rold\u00e1n G, Scott J, George D, Parney I, Easaw J, Cairncross G, Forsyth P, Yan E (2008) Leptomeningeal disease from oligodendroglioma: clinical and molecular analysis. Can J Neurol Sci 35:204\u2013209","journal-title":"Can J Neurol Sci"},{"key":"551_CR10","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1215\/15228517-2008-105","volume":"11","author":"MS Nielsen","year":"2009","unstructured":"Nielsen MS, Christensen HC, Kosteljanetz M, Johansen C (2009) Incidence of an survival from oligodendroglioma in Denmark, 1943\u20132002. Neuro Oncol 11:311\u2013317","journal-title":"Neuro Oncol"},{"key":"551_CR11","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1093\/jnen\/64.6.479","volume":"64","author":"H Ohgaki","year":"2005","unstructured":"Ohgaki H, Kleihues P (2005) Population-based studies on incidence, survival rates, and genetic alterations in astrocytic and oligodendroglial gliomas. J Neuropathol Exp Neurol 64:479\u2013489","journal-title":"J Neuropathol Exp Neurol"},{"key":"551_CR12","doi-asserted-by":"crossref","first-page":"1729","DOI":"10.1007\/s00432-010-0831-x","volume":"136","author":"K Oechsle","year":"2010","unstructured":"Oechsle K, Lange-Brock V, Kruell A, Bokemeyer C, de Wit M (2010) Prognostic factors and treatment options in patients with leptomeningeal metastases of different primary tumors: a retrospective analysis. J Cancer Res Clin Oncol 136:1729\u20131735","journal-title":"J Cancer Res Clin Oncol"},{"key":"551_CR13","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1212\/WNL.0b013e3181dc1a69","volume":"74","author":"JL Clarke","year":"2010","unstructured":"Clarke JL, Perez HR, Jacks LM, Panageas KS, Deangelis LM (2010) Leptomeningeal metastases in the MRI era. Neurology 74:1449\u20131454","journal-title":"Neurology"}],"container-title":["Journal of Neuro-Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.springerlink.com\/index\/pdf\/10.1007\/s11060-011-0551-3","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,6,19]],"date-time":"2017-06-19T20:28:13Z","timestamp":1497904093000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11060-011-0551-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,3,4]]},"references-count":13,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2011,9]]}},"alternative-id":["551"],"URL":"https:\/\/doi.org\/10.1007\/s11060-011-0551-3","relation":{},"ISSN":["0167-594X","1573-7373"],"issn-type":[{"value":"0167-594X","type":"print"},{"value":"1573-7373","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,3,4]]}}}